Evidence map›Paper›PMID 31559266›Full record

ArticleCase reports in nephrology and dialysis

Three Patients with Lithium-Associated Hyperparathyroidism: Literature Review Regarding Medical and Surgical Management.

Ramy M Hanna, Huma Hasnain, Michelle D Sangalang, Jennifer Han, Aarthi Arasu, Farid Arman, Marina Barsoum, Hyunah Poa, Anjay Rastogi, Avital Harari

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in nephrology and dialysis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ramy M HannaUCLA Department of Medicine, Division of Nephrology, Los Angeles, California, USA.
Huma HasnainUCLA Department of Medicine, Division of Nephrology, Los Angeles, California, USA.
Michelle D SangalangUCLA Department of Family Medicine, Los Angeles, California, USA.
Jennifer HanUCLA Department of Medicine, Division of Endocrinology, Los Angeles, California, USA.
Aarthi ArasuUCLA Department of Medicine, Division of Endocrinology, Los Angeles, California, USA.
Farid ArmanUCLA Department of Medicine, Division of Nephrology, Los Angeles, California, USA.
Marina BarsoumUCLA Department of Medicine, Division of Nephrology, Los Angeles, California, USA.
Hyunah PoaUCLA Department of Medicine, Los Angeles, California, USA.
Anjay RastogiUCLA Department of Medicine, Division of Nephrology, Los Angeles, California, USA.
Avital HarariUCLA Department of Surgery, Division of Endocrine Surgery, Los Angeles, California, USA.
University of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lithium (Li) carbonate has been established as a mood stabilizer and an efficacious treatment for bipolar disorder since its discovery by Dr. John Cade in 1948. Li interacts significantly with organ systems and endocrine pathways. One of the most challenging side effects of Li to manage is its effect on the parathyroid glands. Dysregulation of parathyroid signaling due to Li results in hypercalcemia due to increased vitamin D

Indexed as

CalcimimeticsHypercalcemiaLithiumParathyroidectomyParathyroid hormone levelsSecondary hyperparathyroidismTertiary hyperparathyroidism

Identifiers

PMID31559266
PMCPMC6751439
OpenAlexW2969343020

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.